Three researchers have suggested that the success of genomic testing depends on post-market data collection and analysis to help determine its safety and effectiveness. They further claim that Congressional action is needed to "incentivize the development of the massive data systems that doctors and regulators will need in order to make these tests safe and…
Researchers Call for Regulatory Oversight of Genomic Tests
by Glenn S. Demby | Jun 11, 2015 | FDA-nir, Legislation-nir, National Lab Reporter